Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry – The Lancet

In patients with COVID-19 who received ECMO, both estimated mortality 90 days after
ECMO and mortality in those with a final disposition of death or discharge were less
than 40%. These data from 213 hospitals worldwide provide a generalisable estimate
of ECMO…